Health Canada
GUIDANCE FINAL
Health Canada has changed how it screens drug establishment licence applications
Published: 10/15/2026Detected: 10/15/2026
Summary preview
Changes the way Health Canada screens Drug Establishment Licence (DEL) applications, which may affect the review path, documentation expectations, and timing for licence submissions and updates.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free account#Drug Establishment Licence
#DEL
#licence application screening
#compliance readiness
#Health Canada
Official Source Document Source Verified
Access the original document directly from HEALTH CANADA.
More from Health Canada
- Advisory Committee: Review of the Federal Approach to Pandemic Science Advice and Research Coordination10/16/2026
- Advisory Committee: National Pharmacare Committee of Experts10/16/2026
- Advisory Committee: Ministerial Advisory Council on Mental Health10/16/2026
- Advisory Committee: Expert Task Force on Substance Use10/16/2026
- Advisory Committee: Expert Panel on MAID and Mental Illness10/16/2026